Cargando…

Association between vitamin D and prediabetes: A PRISMA-compliant meta-analysis

BACKGROUND: Previous studies showed conflicting results for associations between vitamin D and prediabetes. The study aimed to make a systematic review and meta-analysis for the association between vitamin D and prediabetes. METHODS: We searched for articles identifying associations between vitamin...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Lu, Zhai, Yu, Shen, Shanmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7034644/
https://www.ncbi.nlm.nih.gov/pubmed/32080077
http://dx.doi.org/10.1097/MD.0000000000019034
_version_ 1783499915783045120
author Yu, Lu
Zhai, Yu
Shen, Shanmei
author_facet Yu, Lu
Zhai, Yu
Shen, Shanmei
author_sort Yu, Lu
collection PubMed
description BACKGROUND: Previous studies showed conflicting results for associations between vitamin D and prediabetes. The study aimed to make a systematic review and meta-analysis for the association between vitamin D and prediabetes. METHODS: We searched for articles identifying associations between vitamin D and prediabetes published in English until July 2019 in following databases (PubMed, Web of Science, EMBASE, Medline, Google Scholar, and Cochrane databases). Finally, we conducted these analyses (heterogeneities examination, meta-regression analyses, sensitivity analysis, and publication bias examination) using STATA 12.0 software (Stata Corporation, College Station, TX, USA). Q test and I(2) were applied to examine heterogeneities between studies. RESULTS: Twelve studies were finally included in the present study. The study included 4 studies to explore the association between serum levels of 25-hydroxy (OH) vitamin D and risks of prediabetes (including 3094 participants). Additionally, the present study included 8 studies (including 865 individuals with prediabetes treated with vitamin D supplementation and 715 patients treated with placebo) to assess differences in therapeutic effects between individuals with prediabetes treated with vitamin D supplementation and those treated with placebo. The present study showed no significant associations between low serum levels of 25(OH) vitamin D and high risk of prediabetes. Additionally, the study showed no significant differences in changes of hemoglobin A(1c) (HbA(1c)), fasting plasma glucose (FPG), and homeostatic model assessment of insulin resistance (HOMA-IR) between individuals with prediabetes treated with vitamin D and those patients given placebo, whereas meta-analysis showed significantly greater changes in 2-hour oral glucose tolerance test (2HPG) in individuals with prediabetes treated with vitamin D, compared with individuals with prediabetes treated with placebo. CONCLUSION: The study supported that low serum levels of 25(OH) vitamin D increased the risk of prediabetes. In addition, vitamin D supplementation improves impaired glucose tolerance in prediabetes. However, more large-scale clinical trials are essential to explore the association between vitamin D and prediabetes.
format Online
Article
Text
id pubmed-7034644
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-70346442020-03-10 Association between vitamin D and prediabetes: A PRISMA-compliant meta-analysis Yu, Lu Zhai, Yu Shen, Shanmei Medicine (Baltimore) 4300 BACKGROUND: Previous studies showed conflicting results for associations between vitamin D and prediabetes. The study aimed to make a systematic review and meta-analysis for the association between vitamin D and prediabetes. METHODS: We searched for articles identifying associations between vitamin D and prediabetes published in English until July 2019 in following databases (PubMed, Web of Science, EMBASE, Medline, Google Scholar, and Cochrane databases). Finally, we conducted these analyses (heterogeneities examination, meta-regression analyses, sensitivity analysis, and publication bias examination) using STATA 12.0 software (Stata Corporation, College Station, TX, USA). Q test and I(2) were applied to examine heterogeneities between studies. RESULTS: Twelve studies were finally included in the present study. The study included 4 studies to explore the association between serum levels of 25-hydroxy (OH) vitamin D and risks of prediabetes (including 3094 participants). Additionally, the present study included 8 studies (including 865 individuals with prediabetes treated with vitamin D supplementation and 715 patients treated with placebo) to assess differences in therapeutic effects between individuals with prediabetes treated with vitamin D supplementation and those treated with placebo. The present study showed no significant associations between low serum levels of 25(OH) vitamin D and high risk of prediabetes. Additionally, the study showed no significant differences in changes of hemoglobin A(1c) (HbA(1c)), fasting plasma glucose (FPG), and homeostatic model assessment of insulin resistance (HOMA-IR) between individuals with prediabetes treated with vitamin D and those patients given placebo, whereas meta-analysis showed significantly greater changes in 2-hour oral glucose tolerance test (2HPG) in individuals with prediabetes treated with vitamin D, compared with individuals with prediabetes treated with placebo. CONCLUSION: The study supported that low serum levels of 25(OH) vitamin D increased the risk of prediabetes. In addition, vitamin D supplementation improves impaired glucose tolerance in prediabetes. However, more large-scale clinical trials are essential to explore the association between vitamin D and prediabetes. Wolters Kluwer Health 2020-02-21 /pmc/articles/PMC7034644/ /pubmed/32080077 http://dx.doi.org/10.1097/MD.0000000000019034 Text en Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0
spellingShingle 4300
Yu, Lu
Zhai, Yu
Shen, Shanmei
Association between vitamin D and prediabetes: A PRISMA-compliant meta-analysis
title Association between vitamin D and prediabetes: A PRISMA-compliant meta-analysis
title_full Association between vitamin D and prediabetes: A PRISMA-compliant meta-analysis
title_fullStr Association between vitamin D and prediabetes: A PRISMA-compliant meta-analysis
title_full_unstemmed Association between vitamin D and prediabetes: A PRISMA-compliant meta-analysis
title_short Association between vitamin D and prediabetes: A PRISMA-compliant meta-analysis
title_sort association between vitamin d and prediabetes: a prisma-compliant meta-analysis
topic 4300
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7034644/
https://www.ncbi.nlm.nih.gov/pubmed/32080077
http://dx.doi.org/10.1097/MD.0000000000019034
work_keys_str_mv AT yulu associationbetweenvitamindandprediabetesaprismacompliantmetaanalysis
AT zhaiyu associationbetweenvitamindandprediabetesaprismacompliantmetaanalysis
AT shenshanmei associationbetweenvitamindandprediabetesaprismacompliantmetaanalysis